RAPID DEVELOPMENT OF ENHANCED CLEARANCE AFTER HIGH-DOSE CYCLOPHOSPHAMIDE

[11] PROGRAM PACKAGE FOR SIMULATION AND PARAMETER-ESTIMATION IN PHARMACOKINETIC SYSTEMS [J]. COMPUTER PROGRAMS IN BIOMEDICINE, 1979, 9 (02): : 115 - 134

[12] DECREASED HALF-LIFE OF CYCLOPHOSPHAMIDE IN PATIENTS UNDER CONTINUAL TREATMENT [J]. EUROPEAN JOURNAL OF CANCER, 1979, 15 (01) : 7 - 10

[13] PHARMACOLOGICALLY ACTIVE METABOLITES OF DRUGS AND OTHER FOREIGN COMPOUNDS - CLINICAL, PHARMACOLOGICAL, THERAPEUTIC AND TOXICOLOGICAL CONSIDERATIONS [J]. DRUGS, 1982, 24 (06) : 519 - 542

[14] EADIE MJ, 1983, CLIN EXP NEUROL, V20, P107

[15] P-31 NMR INVESTIGATIONS OF PHOSPHORAMIDE MUSTARD - EVALUATION OF PH CONTROL OVER THE RATE OF INTRA-MOLECULAR CYCLIZATION TO AN AZIRIDINIUM ION AND THE HYDROLYSIS OF THIS REACTIVE ALKYLATOR [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1979, 22 (08) : 897 - 898

[16] ERLICHMAN C, 1988, DRUG RES, V38, P839

[17] ACTIVE-DRUG METABOLITES - AN OVERVIEW OF THEIR RELEVANCE IN CLINICAL PHARMACOKINETICS [J]. CLINICAL PHARMACOKINETICS, 1985, 10 (03) : 216 - 227

[18] Gibaldi M., 1982, PHARMACOKINETICS, V2nd ed., P409

[19] GRAHAM MI, 1983, CANCER CHEMOTH PHARM, V10, P192

[20] CLINICAL PHARMACOKINETICS OF CYCLOPHOSPHAMIDE [J]. CLINICAL PHARMACOKINETICS, 1979, 4 (05) : 380 - 394

[11] PROGRAM PACKAGE FOR SIMULATION AND PARAMETER-ESTIMATION IN PHARMACOKINETIC SYSTEMS [J]. COMPUTER PROGRAMS IN BIOMEDICINE, 1979, 9 (02): : 115 - 134

[12] DECREASED HALF-LIFE OF CYCLOPHOSPHAMIDE IN PATIENTS UNDER CONTINUAL TREATMENT [J]. EUROPEAN JOURNAL OF CANCER, 1979, 15 (01) : 7 - 10

[13] PHARMACOLOGICALLY ACTIVE METABOLITES OF DRUGS AND OTHER FOREIGN COMPOUNDS - CLINICAL, PHARMACOLOGICAL, THERAPEUTIC AND TOXICOLOGICAL CONSIDERATIONS [J]. DRUGS, 1982, 24 (06) : 519 - 542

[14] EADIE MJ, 1983, CLIN EXP NEUROL, V20, P107

[15] P-31 NMR INVESTIGATIONS OF PHOSPHORAMIDE MUSTARD - EVALUATION OF PH CONTROL OVER THE RATE OF INTRA-MOLECULAR CYCLIZATION TO AN AZIRIDINIUM ION AND THE HYDROLYSIS OF THIS REACTIVE ALKYLATOR [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1979, 22 (08) : 897 - 898

[16] ERLICHMAN C, 1988, DRUG RES, V38, P839

[17] ACTIVE-DRUG METABOLITES - AN OVERVIEW OF THEIR RELEVANCE IN CLINICAL PHARMACOKINETICS [J]. CLINICAL PHARMACOKINETICS, 1985, 10 (03) : 216 - 227

[18] Gibaldi M., 1982, PHARMACOKINETICS, V2nd ed., P409

[19] GRAHAM MI, 1983, CANCER CHEMOTH PHARM, V10, P192

[20] CLINICAL PHARMACOKINETICS OF CYCLOPHOSPHAMIDE [J]. CLINICAL PHARMACOKINETICS, 1979, 4 (05) : 380 - 394